-
Study finds 1-in-50 at risk of severe allergic reactions
WASHINGTON — Nearly 1-in-50 people in the United States are at risk of severe allergic reactions, according to a new study announced Monday by the Asthma and Allergy Foundation of America.
According to the study, severe, life-threatening allergic reactions known as anaphylaxis are common in the United States, occurring in about 1.6% of the population. The rate, the study said, is probably higher, and closer to 5.1%. The study was published in the Journal of Allergy and Clinical Immunology.
-
OTC Nasacort will contribute significant incremental dollars to allergy category
Chattem recently announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies. And that means by spring 2014, there will be another allergy powerhouse alongside Allegra, Claritin and Zyrtec.
The September/October 2013 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums Chewy Delights, Alka Seltzer Fruit Chews, Maximum Strength Zantac 150 Cool Mint, Maximum Strength Pepcid AC, Prilosec OTC (Wildberry Flavor), Prevacid 24 Hour, Zegerid OTC and Gas-X.
The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.
